Mesothelioma is a rapidly growing cancer with no current cure. A treatment that could slow the growth of these cells could provide mesothelioma patients with hope for longer lives.
San Diego, CA (PRWEB) June 30, 2015
According to researchers at the University of Hawaii Cancer Center, the anti-inflammatory properties of aspirin, along with other anti-inflammatory compounds, slowed the growth of cancer cells in mice with mesothelioma.
According to “Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression,” published June 11, 2015, scientists at the University of Hawaii Cancer Center, along with colleagues, found that mice with mesothelioma cancer cells who were treated with aspirin and BoxA (an inhibitor of HMGB1) experienced a reduction in malignant mesothelioma growth.
Study authors noted that by giving the inhibitor in conjunction with aspirin, the gastrointestinal side effects of taking high doses of aspirin were avoided.
“This discovery gives hope to mesothelioma patients everywhere,” said Melinda Helbock, Founder of The Law Office of Melinda J. Helbock A.P.C. “Studies have shown that taking aspirin on a daily basis may lower an individual’s risk of developing cancer; and this new study gives hope that it could also slow the growth of existing cancer cells in mesothelioma patients.”
“Mesothelioma is a rapidly growing cancer with no current cure,” Helbock continued. “A treatment that could slow the growth of these cells could provide mesothelioma patients with hope for longer lives.”
Malignant mesothelioma is a rare form of cancer that starts in the cells in the lining of the chest, abdomen or heart.*
About The Law Office of Melinda J. Helbock A.P.C.
The Law Office of Melinda J. Helbock A.P.C. is a personal injury law firm that represents the families of people with mesothelioma. The firm advocates for victims of asbestos exposure. For more information about the firm visit helbocklaw.com or visit http://www.mesotheliomatreatmentcenters.org.